Clinical Trial Update: A Study of Glaucoma or Ocular Hypertension in Patients Within the United States [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for glaucoma or ocular hypertension sponsored by Pfizer/Mylan (Viatris) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Ocular Hypertension, Glaucoma | Phase 3 | Status: COMPLETED